Stock Events

Acadia Pharmaceuticals (ACAD) Q4 2023 Earnings

27FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.43
-0.19
0.06
0.3

Details

Expected EPS
0.3
Actual EPS
0.28
Surprise EPS
-0.02
Surprise Percent
+6.67%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of 0.28 per share for Q4 2023.

0 Comments

Share your thoughts